Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Veri Medtech Holdings's Equity-to-Asset or its related term are showing as below:
VRHID's Equity-to-Asset is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.485 * Ranked among companies with meaningful Equity-to-Asset only.
Veri Medtech Holdings (OTCPK:VRHID) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Veri Medtech Holdings Equity-to-Asset Related Terms
Veri Medtech Holdings Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Veri Medtech Holdings's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veri Medtech Holdings Equity-to-Asset Chart
Veri Medtech Holdings Annual Data
Trend
Dec21
Equity-to-Asset
0.22
Veri Medtech Holdings Semi-Annual Data
Dec21
Equity-to-Asset
0.22
VRHID vs MMVVF, BLMZ, MVNC: Equity-to-Asset Comparison
For the Health Information Services subindustry, Veri Medtech Holdings's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veri Medtech Holdings Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veri Medtech Holdings's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Veri Medtech Holdings's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Veri Medtech Holdings's Equity to Asset Ratio for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veri Medtech Holdings (VRHID) has a Equity-to-Asset of 0.22 as of Dec. 2021. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Veri Medtech Holdings and its competitors.
Is Veri Medtech Holdings' Equity-to-Asset too high?
Veri Medtech Holdings' current Equity-to-Asset is 0.22. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Veri Medtech Holdings' value of 0.22 is 54.6% below this industry median. Overall, Veri Medtech Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Veri Medtech Holdings' Equity-to-Asset compare to MMVVF and BLMZ?
Veri Medtech Holdings' Equity-to-Asset of 0.22 can be compared against companies in the Healthcare Providers & Services industry. The industry median Equity-to-Asset is 0.49. Veri Medtech Holdings' value of 0.22 is 54.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veri Medtech Holdings's current Equity-to-Asset of 0.22 is 54.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Veri Medtech Holdings and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veri Medtech Holdings's current Equity-to-Asset is 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veri Medtech Holdings stock overvalued right now?
Veri Medtech Holdings (VRHID) has a current Equity-to-Asset of 0.22. The current Equity-to-Asset is 0.22 and 54.6% below the Healthcare Providers & Services industry median of 0.49. Veri Medtech Holdings' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Veri Medtech Holdings (VRHID), the current Equity-to-Asset is 0.22 as of Dec. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Veri Medtech Holdings Inc is a healthcare technology company that offers alternative medicine, personalized diagnostics, and wellness medication on demand. The company leverages telehealth infrastructure, diagnostic intelligence, and scalable digital systems to meet the growing demand for accessible, stigma-free healthcare. Strategically positioned for growth, Veri MedTech actively explores acquisitions that complement its core capabilities and enhance patient engagement across emerging sectors of alternative medicine, longevity, and wellness science. With an integration and operational efficiency track record, the company drives accelerated revenue through the continuous generation of high-value patient databases and recurring service models.
35GF Score
Get the complete analysis for VRHID
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VRHID has been successfully added to your 
